{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:36:02Z","timestamp":1787020562656,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG054324"],"award-info":[{"award-number":["R01AG054324"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["177334"],"award-info":[{"award-number":["177334"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian HIV Trials Network, Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CTNPT043"],"award-info":[{"award-number":["CTNPT043"]}],"id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9seau SIDA et maladies infectieuses du Fonds de recherche du Qu\u00e9bec-Sant\u00e9"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"DOI":"10.1186\/s12979-026-00566-8","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:33:33Z","timestamp":1777296813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Ana-Karla","family":"Diego-Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayluz","family":"Frias Boligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph-Sydney","family":"Mboumba Bouassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Chartrand-Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Messier-Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Giffard-Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Margolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronela","family":"Ancuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia T.","family":"Costiniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Ali","family":"Jenabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"566_CR1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3389\/fimmu.2019.01965","volume":"10","author":"H Babu","year":"2019","unstructured":"Babu H, Ambikan AT, Gabriel EE, Svensson Akusj\u00e4rvi S, Palaniappan AN, Sundaraj V, et al. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front Immunol. 2019;10:1965.","journal-title":"Front Immunol"},{"issue":"9939","key":"566_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens G, Celum C, Lewin SR. Hiv infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258\u201371.","journal-title":"Lancet"},{"issue":"4","key":"566_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39(4):633\u201345.","journal-title":"Immunity"},{"issue":"2","key":"566_CR4","first-page":"101","volume":"13","author":"RJ Henning","year":"2023","unstructured":"Henning RJ, Greene JN. The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. Am J Cardiovasc Dis. 2023;13(2):101.","journal-title":"Am J Cardiovasc Dis"},{"issue":"11","key":"566_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"AS Shah","year":"2018","unstructured":"Shah AS, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100\u201312.","journal-title":"Circulation"},{"issue":"3","key":"566_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1148\/radiol.2021203297","volume":"299","author":"I Boldeanu","year":"2021","unstructured":"Boldeanu I, Sadouni M, Mansour S, Baril J-G, Trottier B, Soulez G, et al. Prevalence and characterization of subclinical coronary atherosclerotic plaque with CT among individuals with HIV: results from the Canadian HIV and Aging Cohort Study. Radiology. 2021;299(3):571\u201380.","journal-title":"Radiology"},{"issue":"7","key":"566_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/14787210.2020.1757430","volume":"18","author":"P McGettrick","year":"2020","unstructured":"McGettrick P, Mallon PW, Sabin CA. Cardiovascular disease in HIV patients: recent advances in predicting and managing risk. Expert Rev Anti-infect Ther. 2020;18(7):677\u201388.","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"12","key":"566_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","volume":"16","author":"PY Hsue","year":"2019","unstructured":"Hsue PY, Waters DD. Hiv infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019;16(12):745\u201359.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"566_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/infdis\/jiv037","volume":"212","author":"M-A Jenabian","year":"2015","unstructured":"Jenabian M-A, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, et al. Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection. J Infect Dis. 2015;212(3):355\u201366.","journal-title":"J Infect Dis"},{"key":"566_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.03.024","volume":"30","author":"CP Neff","year":"2018","unstructured":"Neff CP, Krueger O, Xiong K, Arif S, Nusbacher N, Schneider JM, et al. Fecal microbiota composition drives immune activation in HIV-infected individuals. EBioMedicine. 2018;30:192\u2013202.","journal-title":"EBioMedicine"},{"key":"566_CR11","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.ajpc.2020.100130","volume":"4","author":"A Alfaddagh","year":"2020","unstructured":"Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, et al. Inflammation and cardiovascular disease: from mechanisms to therapeutics. Am J Prev Cardiol. 2020;4:100130.","journal-title":"Am J Prev Cardiol"},{"issue":"21","key":"566_CR12","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.3390\/ijms20215293","volume":"20","author":"B Herrero-Fernandez","year":"2019","unstructured":"Herrero-Fernandez B, Gomez-Bris R, Somovilla-Crespo B, Gonzalez-Granado JM. Immunobiology of atherosclerosis: a complex net of interactions. Int J Mol Sci. 2019;20(21):5293.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"566_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/cvr\/cvx226","volume":"114","author":"S Mundi","year":"2018","unstructured":"Mundi S, Massaro M, Scoditti E, Carluccio MA, Van Hinsbergh VW, Iruela-Arispe ML, et al. Endothelial permeability, LDL deposition, and cardiovascular risk factors\u2014A review. Cardiovasc Res. 2018;114(1):35\u201352.","journal-title":"Cardiovasc Res"},{"key":"566_CR14","doi-asserted-by":"crossref","unstructured":"Li B, Lindner E, Abuhalimeh R, Shaikh F, Younes H, Abuhalimeh B, et al. Interferon gamma and tumor necrosis factor alpha are inflammatory biomarkers for Major adverse cardiovascular events in patients with peripheral artery disease. Biomedicines. 2025;13(7):1586.","DOI":"10.3390\/biomedicines13071586"},{"issue":"13","key":"566_CR15","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1097\/QAD.0000000000001149","volume":"30","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Ma YF, Hur S, Li D, Rupert A, Scherzer R, et al. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy. AIDS. 2016;30(13):2065\u201374.","journal-title":"AIDS"},{"issue":"2","key":"566_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","volume":"32","author":"H Schuett","year":"2012","unstructured":"Schuett H, Oestreich R, Waetzig GH, Annema W, Luchtefeld M, Hillmer A, et al. Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2012;32(2):281\u201390.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"566_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","volume":"55","author":"MS Madhur","year":"2010","unstructured":"Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, et al. Interleukin 17 promotes angiotensin II\u2013induced hypertension and vascular dysfunction. Hypertension. 2010;55(2):500\u20137.","journal-title":"Hypertension"},{"issue":"4","key":"566_CR18","doi-asserted-by":"publisher","first-page":"e011450","DOI":"10.1161\/JAHA.118.011450","volume":"9","author":"SK Masenga","year":"2020","unstructured":"Masenga SK, Elijovich F, Hamooya BM, Nzala S, Kwenda G, Heimburger DC, et al. Elevated eosinophils as a feature of inflammation associated with hypertension in virally suppressed people living with HIV. J Am Heart Assoc. 2020;9(4):e011450.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"566_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12872-024-03897-w","volume":"24","author":"Y Miao","year":"2024","unstructured":"Miao Y, Yan T, Liu J, Zhang C, Yan J, Xu L, et al. Meta-analysis of the association between interleukin-17 and ischemic cardiovascular disease. BMC Cardiovasc Disord. 2024;24(1):252.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"566_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1086\/503261","volume":"42","author":"A Solages","year":"2006","unstructured":"Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, et al. Endothelial function in HIV-infected persons. Clin Infect Dis. 2006;42(9):1325\u201332.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"566_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/QAD.0000000000003196","volume":"36","author":"CN Wanjalla","year":"2022","unstructured":"Wanjalla CN, Temu TM, Mashayekhi M, Warren CM, Shepherd BE, Gangula R, et al. Interleukin-17A is associated with flow-mediated dilation and interleukin-4 with carotid plaque in persons with HIV. AIDS. 2022;36(7):963\u201373.","journal-title":"AIDS"},{"issue":"1","key":"566_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.122.057443","volume":"147","author":"M Ntsekhe","year":"2023","unstructured":"Ntsekhe M, Baker JV. Cardiovascular disease among persons living with HIV: new insights into pathogenesis and clinical manifestations in a global context. Circulation. 2023;147(1):83\u2013100.","journal-title":"Circulation"},{"key":"566_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","volume":"5","author":"AR Anand","year":"2018","unstructured":"Anand AR, Rachel G, Parthasarathy D. HIV proteins and endothelial dysfunction: implications in cardiovascular disease. Front Cardiovasc Med. 2018;5:185.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"566_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2012.6698","volume":"308","author":"S Subramanian","year":"2012","unstructured":"Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379\u201386.","journal-title":"JAMA"},{"issue":"13","key":"566_CR25","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1097\/QAD.0000000000001149","volume":"30","author":"CH Denise","year":"2016","unstructured":"Denise CH, Fei Y, Sophia H, Danny L, Rupert A, Scherzer R, et al. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive ART. AIDS (London, England). 2016;30(13):2065.","journal-title":"AIDS (London, England)."},{"issue":"8","key":"566_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jir520","volume":"204","author":"TH Burdo","year":"2011","unstructured":"Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204(8):1227\u201336.","journal-title":"J Infect Dis"},{"issue":"9","key":"566_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/infdis\/jix082","volume":"215","author":"DB Hanna","year":"2017","unstructured":"Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, et al. Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men. J Infect Dis. 2017;215(9):1352\u201361.","journal-title":"J Infect Dis"},{"key":"566_CR28","doi-asserted-by":"crossref","unstructured":"Longenecker CT, Funderburg NT, Jiang Y, Debanne S, Storer N, Labbato DE, et al. Markers of inflammation and CD8 T\u2010cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV\u2010infected individuals. HIV Medi. 2013;14(6):385\u201390.","DOI":"10.1111\/hiv.12013"},{"issue":"4","key":"566_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/infdis\/jiq071","volume":"203","author":"RC Kaplan","year":"2011","unstructured":"Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis. 2011;203(4):452\u201363.","journal-title":"J Infect Dis"},{"issue":"1","key":"566_CR30","doi-asserted-by":"publisher","first-page":"e0227365","DOI":"10.1371\/journal.pone.0227365","volume":"15","author":"A Lund","year":"2020","unstructured":"Lund A, Nordrehaug JE, Slettom G, Hafstad Solvang S-E, Ringdal Pedersen EK, Midttun \u00d8, et al. Plasma kynurenines and prognosis in patients with heart failure. PLoS One. 2020;15(1):e0227365.","journal-title":"PLoS One"},{"key":"566_CR31","doi-asserted-by":"crossref","unstructured":"Routy JP, Mehraj V, Vyboh K, Cao W, Kema I, Jenabian MA. Clinical relevance of kynurenine pathway in HIV\/AIDS: an immune checkpoint at the crossroads of metabolism and inflammation. AIDS Rev. 2015;17(2).","DOI":"10.1007\/978-3-319-11870-3_9"},{"key":"566_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-021-02140-0","volume":"21","author":"N Wongpraparut","year":"2021","unstructured":"Wongpraparut N, Pengchata P, Piyophirapong S, Panchavinnin P, Pongakasira R, Arechep N, et al. Indoleamine 2, 3 dioxygenase (IDO) level as a marker for significant coronary artery disease. BMC Cardiovasc Disord. 2021;21:1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"566_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/biomedicines9070734","volume":"9","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, T\u00f3th F, Poly\u00e1k H, Szab\u00f3 \u00c1, M\u00e1ndi Y, V\u00e9csei L. Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway. Biomedicines. 2021;9(7):734.","journal-title":"Biomedicines"},{"issue":"32","key":"566_CR34","doi-asserted-by":"publisher","first-page":"32ra6","DOI":"10.1126\/scitranslmed.3000632","volume":"2","author":"D Favre","year":"2010","unstructured":"Favre D, Mold J, Hunt PW, Kanwar B, Loke Pn, Seu L, et al. Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med. 2010;2(32):32ra6-ra6.","journal-title":"Sci Transl Med"},{"issue":"10","key":"566_CR35","doi-asserted-by":"publisher","first-page":"e78146","DOI":"10.1371\/journal.pone.0078146","volume":"8","author":"M-A Jenabian","year":"2013","unstructured":"Jenabian M-A, Patel M, Kema I, Kanagaratham C, Radzioch D, Thebault P, et al. Distinct tryptophan catabolism and Th17\/Treg balance in HIV progressors and elite controllers. PLoS One. 2013;8(10):e78146.","journal-title":"PLoS One"},{"issue":"9","key":"566_CR36","doi-asserted-by":"publisher","first-page":"e74551","DOI":"10.1371\/journal.pone.0074551","volume":"8","author":"R Planes","year":"2013","unstructured":"Planes R, Bahraoui E. HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. PLoS One. 2013;8(9):e74551.","journal-title":"PLoS One"},{"issue":"4","key":"566_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1542-4758.2010.00464.x","volume":"14","author":"A Kato","year":"2010","unstructured":"Kato A, Suzuki Y, Suda T, Suzuki M, Fujie M, Takita T, et al. Relationship between an increased serum kynurenine\/tryptophan ratio and atherosclerotic parameters in hemodialysis patients. Hemodial Int. 2010;14(4):418\u201324.","journal-title":"Hemodial Int"},{"issue":"8","key":"566_CR38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/00365510802245685","volume":"68","author":"P Niinisalo","year":"2008","unstructured":"Niinisalo P, Raitala A, Pertovaara M, Oja S, Lehtim\u00e4ki T, K\u00e4h\u00f6nen M, et al. Indoleamine 2, 3\u2010dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest. 2008;68(8):767\u201370.","journal-title":"Scand J Clin Lab Invest"},{"key":"566_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2015.03.413","volume":"189","author":"SJ Eussen","year":"2015","unstructured":"Eussen SJ, Ueland PM, Vollset SE, Nyg\u00e5rd O, Midttun \u00d8, Sulo G, et al. Kynurenines as predictors of acute coronary events in the Hordaland Health Study. Int J Cardiol. 2015;189:18\u201324.","journal-title":"Int J Cardiol"},{"issue":"2","key":"566_CR40","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ijcard.2012.12.090","volume":"168","author":"G Sulo","year":"2013","unstructured":"Sulo G, Vollset SE, Nyg\u00e5rd O, Midttun \u00d8, Ueland PM, Eussen SJ, et al. Neopterin and kynurenine\u2013tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int J Cardiol. 2013;168(2):1435\u201340.","journal-title":"Int J Cardiol"},{"issue":"10","key":"566_CR41","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/QAD.0000000000002255","volume":"33","author":"AC Kearns","year":"2019","unstructured":"Kearns AC, Velasquez S, Liu F, Dai S, Chen Y, Lehmicke G, et al. Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis. AIDS. 2019;33(10):1557\u201364.","journal-title":"AIDS"},{"issue":"2","key":"566_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/cid\/ciy053","volume":"67","author":"Q Qi","year":"2018","unstructured":"Qi Q, Hua S, Clish CB, Scott JM, Hanna DB, Wang T, et al. Plasma tryptophan-kynurenine metabolites are altered in human immunodeficiency virus infection and associated with progression of carotid artery atherosclerosis. Clin Infect Dis. 2018;67(2):235\u201342.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"566_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/QAD.0000000000003596","volume":"38","author":"K Luo","year":"2024","unstructured":"Luo K, Wang Z, Peters BA, Hanna DB, Wang T, Sollecito CC, et al. Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection. AIDS. 2024;38(2):223\u201333.","journal-title":"AIDS"},{"key":"566_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2692-2","volume":"17","author":"M Durand","year":"2017","unstructured":"Durand M, Chartrand-Lefebvre C, Baril J-G, Trottier S, Trottier B, Harris M, et al. The Canadian HIV and aging cohort study-determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol. BMC Infect Dis. 2017;17:1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"566_CR45","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/hiv.13550","volume":"24","author":"K Gigu\u00e8re","year":"2023","unstructured":"Gigu\u00e8re K, Chartrand-Lefebvre C, Baril JG, Conway B, El-Far M, Falutz J, et al. Baseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV. HIV Med. 2023;24(12):1210\u201321.","journal-title":"HIV Med"},{"issue":"10","key":"566_CR46","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1097\/QAD.0000000000002911","volume":"35","author":"M Sadouni","year":"2021","unstructured":"Sadouni M, Durand M, Boldeanu I, Danieli C, Bodson-Clermont P, Mansour S, et al. Association of epicardial fat with noncalcified coronary plaque volume and with low attenuation plaque in people with HIV. AIDS. 2021;35(10):1575\u201384.","journal-title":"AIDS"},{"key":"566_CR47","doi-asserted-by":"crossref","unstructured":"Mboumba Bouassa R-S, Comeau E, Alexandrova Y, Pagliuzza A, Yero A, Samarani S, et al. Effects of oral cannabinoids on systemic inflammation and viral reservoir markers in people with HIV on antiretroviral therapy: results of the CTN PT028 pilot clinical trial. Cells. 2023;12(14):1811.","DOI":"10.3390\/cells12141811"},{"issue":"9","key":"566_CR48","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1111\/jnc.16137","volume":"168","author":"K Visser","year":"2024","unstructured":"Visser K, Ciubotariu D, de Koning ME, Jacobs B, van Faassen M, van der Ley C, et al. Exploring the kynurenine pathway in mild traumatic brain injury: A longitudinal study. J Neurochem. 2024;168(9):2710\u201321.","journal-title":"J Neurochem"},{"issue":"14","key":"566_CR49","doi-asserted-by":"publisher","first-page":"7157","DOI":"10.1080\/03610926.2016.1143510","volume":"46","author":"F Chen","year":"2017","unstructured":"Chen F, Nkurunziza S. On estimation of the change points in multivariate regression models with structural changes. Commun Stat Theory Methods. 2017;46(14):7157\u201373.","journal-title":"Commun Stat Theory Methods"},{"issue":"1","key":"566_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08982119808919208","volume":"11","author":"F Wang","year":"1998","unstructured":"Wang F, Chen JC. Capability index using principal components analysis. Qual Eng. 1998;11(1):21\u20137.","journal-title":"Qual Eng"},{"issue":"1","key":"566_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/infdis\/jiz423","volume":"221","author":"S Isnard","year":"2020","unstructured":"Isnard S, Ramendra R, Dupuy FP, Lin J, Fombuena B, Kokinov N, et al. Plasma levels of C-Type Lectin REG3alpha and gut damage in people with human immunodeficiency virus. J Infect Dis. 2020;221(1):110\u201321.","journal-title":"J Infect Dis"},{"issue":"6","key":"566_CR52","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","volume":"203","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780\u201390.","journal-title":"J Infect Dis"},{"issue":"2","key":"566_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/nu15020256","volume":"15","author":"V Theiler-Schwetz","year":"2023","unstructured":"Theiler-Schwetz V, Trummer C, Gr\u00fcbler MR, Keppel MH, Zittermann A, Tomaschitz A, et al. Associations of parameters of the tryptophan\u2013kynurenine pathway with cardiovascular risk factors in hypertensive patients. Nutrients. 2023;15(2):256.","journal-title":"Nutrients"},{"key":"566_CR54","doi-asserted-by":"publisher","first-page":"1173956","DOI":"10.3389\/fimmu.2023.1173956","volume":"14","author":"J Ouyang","year":"2023","unstructured":"Ouyang J, Yan J, Zhou X, Isnard S, Harypursat V, Cui H, et al. Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV. Front Immunol. 2023;14:1173956.","journal-title":"Front Immunol"},{"issue":"4","key":"566_CR55","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78(4):1233\u201361.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"566_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","volume":"115","author":"NT Funderburg","year":"2010","unstructured":"Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010;115(2):161\u20137.","journal-title":"Blood"},{"issue":"6","key":"566_CR57","doi-asserted-by":"publisher","first-page":"ofab109","DOI":"10.1093\/ofid\/ofab109","volume":"8","author":"S Isnard","year":"2021","unstructured":"Isnard S, Fombuena B, Sadouni M, Lin J, Richard C, Routy B, et al. Circulating beta-d-Glucan as a Marker of Subclinical Coronary Plaque in Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021;8(6):ofab109.","journal-title":"Open Forum Infect Dis."},{"issue":"1","key":"566_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12933-024-02509-3","volume":"23","author":"M Narum","year":"2024","unstructured":"Narum M, Seljeflot I, Bratseth V, Berg TJ, Sveen KA. Intestinal fatty acid binding protein is associated with coronary artery disease in long-term type 1 diabetes-the Dialong study. Cardiovasc Diabetol. 2024;23(1):419.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"566_CR59","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/nu17010072","volume":"17","author":"F Maqoud","year":"2024","unstructured":"Maqoud F, Calabrese FM, Celano G, Mallardi D, Goscilo F, D\u2019Attoma B, et al. Role of increasing body mass index in gut barrier dysfunction, systemic inflammation, and metabolic dysregulation in obesity. Nutrients. 2024;17(1):72.","journal-title":"Nutrients"},{"key":"566_CR60","doi-asserted-by":"crossref","unstructured":"Cheru LT, Park EA, Saylor CF, Burdo TH, Fitch KV, Looby S, et al., editors. I-FABP is higher in people with chronic HIV than elite controllers, related to sugar and fatty acid intake and inversely related to body fat in people with HIV. Open forum infectious diseases. Oxford University Press US; 2018.","DOI":"10.1093\/ofid\/ofy288"},{"issue":"6","key":"566_CR61","doi-asserted-by":"publisher","first-page":"e014241","DOI":"10.1161\/JAHA.119.014241","volume":"9","author":"NC Olson","year":"2020","unstructured":"Olson NC, Koh I, Reiner AP, Judd SE, Irvin MR, Howard G, et al. Soluble CD14, ischemic stroke, and coronary heart disease risk in a prospective study: The REGARDS cohort. J Am Heart Assoc. 2020;9(6):e014241.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"566_CR62","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1161\/ATVBAHA.121.316035","volume":"41","author":"MA Stanislawski","year":"2021","unstructured":"Stanislawski MA, Lange LA, Raffield LM, Zakai NA, Meyer M, Ferrier K, et al. Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants. Arterioscler Thromb Vasc Biol. 2021;41(6):e369\u201378.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"566_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/QAD.0000000000001682","volume":"32","author":"CT Longenecker","year":"2018","unstructured":"Longenecker CT, Sullivan CE, Morrison J, Hileman CO, Zidar DA, Gilkeson R, et al. The effects of HIV and smoking on aortic and splenic inflammation. AIDS. 2018;32(1):89\u201394.","journal-title":"AIDS"},{"issue":"2","key":"566_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2016.4728","volume":"2","author":"A Tawakol","year":"2017","unstructured":"Tawakol A, Ishai A, Li D, Takx RA, Hur S, Kaiser Y, et al. Association of arterial and lymph node inflammation with distinct inflammatory pathways in human immunodeficiency virus infection. JAMA cardiology. 2017;2(2):163\u201371.","journal-title":"JAMA cardiology"},{"issue":"6","key":"566_CR65","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2337\/diacare.28.6.1376","volume":"28","author":"I Shai","year":"2005","unstructured":"Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, et al. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care. 2005;28(6):1376\u201382.","journal-title":"Diabetes Care"},{"issue":"10","key":"566_CR66","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","volume":"119","author":"RE Eid","year":"2009","unstructured":"Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation. 2009;119(10):1424\u201332.","journal-title":"Circulation"},{"issue":"2","key":"566_CR67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/ATVBAHA.114.304674","volume":"35","author":"ER Pedersen","year":"2015","unstructured":"Pedersen ER, Tuseth N, Eussen SJ, Ueland PM, Strand E, Svingen GF, et al. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol. 2015;35(2):455\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"566_CR68","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jnc.13496","volume":"136","author":"J de Bie","year":"2016","unstructured":"de Bie J, Guest J, Guillemin GJ, Grant R. Central kynurenine pathway shift with age in women. J Neurochem. 2016;136(5):995\u20131003.","journal-title":"J Neurochem"},{"issue":"2","key":"566_CR69","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.numecd.2014.11.004","volume":"25","author":"A Zinellu","year":"2015","unstructured":"Zinellu A, Sotgia S, Mangoni AA, Sanna M, Satta AE, Carru C. Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement. Nutr Metab Cardiovasc Dis. 2015;25(2):153\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"566_CR70","doi-asserted-by":"crossref","unstructured":"Bouassa R-SM, Giorgini G, Silvestri C, Muller C, Nallabelli N, Alexandrova Y, et al. Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: results from the Canadian HIV and Aging Cohort Study. iScience. 2024;27(8).","DOI":"10.1016\/j.isci.2024.110456"},{"issue":"4","key":"566_CR71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/aje\/kwv242","volume":"183","author":"H Zuo","year":"2016","unstructured":"Zuo H, Ueland PM, Ulvik A, Eussen SJ, Vollset SE, Nyg\u00e5rd O, et al. Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study. Am J Epidemiol. 2016;183(4):249\u201358.","journal-title":"Am J Epidemiol"},{"key":"566_CR72","doi-asserted-by":"publisher","first-page":"1343361","DOI":"10.3389\/fcvm.2024.1343361","volume":"11","author":"MA Frias","year":"2024","unstructured":"Frias MA, Pagano S, Bararpour N, Sidib\u00e9 J, Kamau F, F\u00e9taud-Lapierre V, et al. People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case\u2013control study. Front Cardiovas Med. 2024;11:1343361.","journal-title":"Front Cardiovas Med"},{"key":"566_CR73","doi-asserted-by":"publisher","first-page":"845942","DOI":"10.3389\/fcvm.2022.845942","volume":"9","author":"Y Gui","year":"2022","unstructured":"Gui Y, Zheng H, Cao RY. Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms. Front Cardiovasc Med. 2022;9:845942.","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"566_CR74","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","volume":"129","author":"S Allahverdian","year":"2014","unstructured":"Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation. 2014;129(15):1551\u20139.","journal-title":"Circulation"},{"issue":"17","key":"566_CR75","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","volume":"62","author":"A Ghattas","year":"2013","unstructured":"Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol. 2013;62(17):1541\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"566_CR76","first-page":"1584","volume":"39","author":"F Hosseini","year":"2023","unstructured":"Hosseini F, Franco C, Whalen BA, Taylor CM, Sellers SL, Khan N, et al. Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis. Can J Cardiol. 2023;39(11):1584\u20136.","journal-title":"Can J Cardiol"},{"issue":"1","key":"566_CR77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/CIRCGENETICS.111.960385","volume":"5","author":"KE Berg","year":"2012","unstructured":"Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN, et al. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012;5(1):122\u201331.","journal-title":"Circ Cardiovasc Genet"},{"key":"566_CR78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnagi.2016.00029","volume":"8","author":"A ElAli","year":"2016","unstructured":"ElAli A, Jean LeBlanc N. The role of monocytes in ischemic stroke pathobiology: new avenues to explore. Front Aging Neurosci. 2016;8:29.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"566_CR79","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/jcbfm.2009.25","volume":"29","author":"X Urra","year":"2009","unstructured":"Urra X, Villamor N, Amaro S, Gomez-Choco M, Obach V, Oleaga L, et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab. 2009;29(5):994\u20131002.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"566_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/cells13020157","volume":"13","author":"TR Wiche Salinas","year":"2024","unstructured":"Wiche Salinas TR, Zhang Y, Gosselin A, Rosario NF, El-Far M, Filali-Mouhim A, et al. Alterations in Th17 cells and non-classical monocytes as a signature of subclinical coronary artery atherosclerosis during ART-treated HIV-1 infection. Cells. 2024;13(2):157.","journal-title":"Cells"},{"issue":"6696","key":"566_CR81","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/29788","volume":"394","author":"L Boring","year":"1998","unstructured":"Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2\u2212\/\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394(6696):894\u20137.","journal-title":"Nature"},{"issue":"13","key":"566_CR82","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1161\/CIRCULATIONAHA.107.743872","volume":"117","author":"N Saederup","year":"2008","unstructured":"Saederup N, Chan L, Lira SA, Charo IF. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2\u2212\/\u2212 mice: evidence for independent chemokine functions in atherogenesis. Circulation. 2008;117(13):1642\u20138.","journal-title":"Circulation"},{"issue":"3","key":"566_CR83","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cvr\/cvx224","volume":"114","author":"SL Verweij","year":"2018","unstructured":"Verweij SL, Duivenvoorden R, Stiekema LCA, Nurmohamed NS, van der Valk FM, Versloot M, et al. CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET\/CT in patients at risk for cardiovascular disease. Cardiovasc Res. 2018;114(3):468\u201375.","journal-title":"Cardiovasc Res"},{"key":"566_CR84","doi-asserted-by":"publisher","first-page":"975367","DOI":"10.3389\/fimmu.2022.975367","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yang K, Chen F, Liu Q, Ni J, Cao W, et al. Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications. Front Immunol. 2022;13:975367.","journal-title":"Front Immunol"},{"issue":"3","key":"566_CR85","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/v11030200","volume":"11","author":"S Zicari","year":"2019","unstructured":"Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11(3):200.","journal-title":"Viruses"},{"key":"566_CR86","doi-asserted-by":"publisher","first-page":"101471","DOI":"10.1016\/j.smim.2021.101471","volume":"51","author":"CW Cai","year":"2021","unstructured":"Cai CW, Sereti I. Residual immune dysfunction under antiretroviral therapy. Semin Immunol. 2021;51:101471.","journal-title":"Semin Immunol"},{"issue":"17","key":"566_CR87","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jacc.2022.08.756","volume":"80","author":"S Kundu","year":"2022","unstructured":"Kundu S, Freiberg MS, Tracy RP, So-Armah KA, Koethe JR, Duncan MS, et al. Circulating T cells and cardiovascular risk in people with and without HIV infection. J Am Coll Cardiol. 2022;80(17):1633\u201344.","journal-title":"J Am Coll Cardiol"},{"key":"566_CR88","doi-asserted-by":"crossref","unstructured":"Augustin M, Horn C, Ercanoglu MS, Sandaradura de Silva U, Bondet V, Suarez I, et al. CXCR3 expression pattern on CD4+ T cells and IP-10 levels with regard to the HIV-1 reservoir in the gut-associated lymphatic tissue. Pathogens. 2022;11(4):483.","DOI":"10.3390\/pathogens11040483"},{"issue":"6","key":"566_CR89","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2015.05.014","volume":"42","author":"I Komarowska","year":"2015","unstructured":"Komarowska I, Coe D, Wang G, Haas R, Mauro C, Kishore M, et al. Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release. Immunity. 2015;42(6):1087\u201399.","journal-title":"Immunity"},{"issue":"6","key":"566_CR90","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.immuni.2015.06.001","volume":"42","author":"D Wolf","year":"2015","unstructured":"Wolf D, Li J, Ley K. HGF guides T cells into the heart. Immunity. 2015;42(6):979\u201381.","journal-title":"Immunity"},{"issue":"6","key":"566_CR91","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007;204(6):1257\u201365.","journal-title":"J Exp Med"},{"issue":"4","key":"566_CR92","doi-asserted-by":"publisher","first-page":"e1003319","DOI":"10.1371\/journal.ppat.1003319","volume":"9","author":"M-A Jenabian","year":"2013","unstructured":"Jenabian M-A, Seddiki N, Yatim A, Carriere M, Hulin A, Younas M, et al. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39\/adenosine pathway in HIV infection. PLoS Pathog. 2013;9(4):e1003319.","journal-title":"PLoS Pathog"},{"key":"566_CR93","doi-asserted-by":"crossref","unstructured":"Quast C, Alter C, Ding Z, Borg N, Schrader J. Adenosine formed by CD73 on T cells inhibits cardiac inflammation and fibrosis and preserves contractile function in transverse aortic constriction\u2013induced heart failure. Circulation: Heart Failure. 2017;10(4):e003346.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003346"},{"issue":"16","key":"566_CR94","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.107.690180","volume":"116","author":"D Kohler","year":"2007","unstructured":"Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, et al. CD39\/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia\/reperfusion injury. Circulation. 2007;116(16):1784\u201394.","journal-title":"Circulation"},{"issue":"7","key":"566_CR95","doi-asserted-by":"publisher","first-page":"e1002110","DOI":"10.1371\/journal.ppat.1002110","volume":"7","author":"M Nikolova","year":"2011","unstructured":"Nikolova M, Carriere M, Jenabian M-A, Limou S, Younas M, K\u00f6k A, et al. CD39\/adenosine pathway is involved in AIDS progression. PLoS Pathog. 2011;7(7):e1002110.","journal-title":"PLoS Pathog"},{"key":"566_CR96","doi-asserted-by":"publisher","unstructured":"Yero A, Farnos O, Rabezanahary H, Racine G, Estaquier J, Jenabian M-A. Differential dynamics of regulatory T-cell and Th17 cell balance in mesenteric lymph nodes and blood following early antiretroviral initiation during acute simian immunodeficiency virus infection. Journal of virology. 2019;93(19). https:\/\/doi.org\/10.1128\/jvi.00371-19.","DOI":"10.1128\/jvi.00371-19"},{"key":"566_CR97","doi-asserted-by":"publisher","first-page":"103570","DOI":"10.1016\/j.ebiom.2021.103570","volume":"71","author":"A Yero","year":"2021","unstructured":"Yero A, Shi T, Farnos O, Routy JP, Tremblay C, Durand M, et al. Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection. EBioMedicine. 2021;71:103570.","journal-title":"EBioMedicine"},{"issue":"7","key":"566_CR98","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/QAD.0000000000002842","volume":"35","author":"C Rothan","year":"2021","unstructured":"Rothan C, Yero A, Shi T, Farnos O, Chartrand-Lefebvre C, El-Far M, et al. Antiretroviral therapy-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature. AIDS. 2021;35(7):1003\u201314.","journal-title":"AIDS"},{"key":"566_CR99","doi-asserted-by":"crossref","unstructured":"Zhang H, Xia H, Shi F, Li Q, Weissman S, Li X, Yang X. Sex differences in cardiovascular disease and associated factors in people living with HIV: Evidence from All of Us program. HIV Med. 2026;27(3):397\u2013408.","DOI":"10.1111\/hiv.70155"},{"issue":"5","key":"566_CR100","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/COH.0000000000000756","volume":"17","author":"K Kentoffio","year":"2022","unstructured":"Kentoffio K, Temu TM, Shakil SS, Zanni MV, Longenecker CT. Cardiovascular disease risk in women living with HIV. Curr Opin HIV AIDS. 2022;17(5):270\u20138.","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Immunity & Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-026-00566-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-026-00566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-026-00566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:01:57Z","timestamp":1777654917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12979-026-00566-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1186\/s12979-026-00566-8","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was authorized by the research ethics board of the Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) (CE 11.063), MUHC: MP-37\u20132022-8107 and UQAM: 2022\u20134663. Written informed consent was obtained from all participants prior to their inclusion in the CHACS study biobanking.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}